The information contained here is purely for informational purposes and does not, in any event, seek to take the place of a consultation with a medical professional. In the event of doubt or if you have symptoms, you should always consult a medical professional.
Expanded Access or Right to Try in the United States:
There is an Expanded Access Program (EAP) for lurbinectedin to treat patients in the United States (U.S.) with relapsed Small Cell Lung Cancer (SCLC), who are unable to enter clinical trials and there are no appropriate alternative treatments.
Healthcare professionals wishing to request access to lurbinectedin under the EAP or who would like to find out more should do so by emailing Lurbinectedin.EAP@Bionical-Emas.com.